Soriano-Sarabia N - Search Results

1

In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals.

Garrido C, Tolstrup M, Søgaard OS, Rasmussen TA, Allard B, Soriano-Sarabia N, Archin NM, Margolis DM. Garrido C, et al. AIDS. 2019 Mar 15;33(4):605-613. doi: 10.1097/QAD.0000000000002112. AIDS. 2019. PMID: 30830886 Free PMC article. Clinical Trial.

2

Prospects for treatment of latent HIV.

Barton KM, Burch BD, Soriano-Sarabia N, Margolis DM. Barton KM, et al. Clin Pharmacol Ther. 2013 Jan;93(1):46-56. doi: 10.1038/clpt.2012.202. Epub 2012 Oct 10. Clin Pharmacol Ther. 2013. PMID: 23212106 Free PMC article. Review.

3

Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells.

Soriano-Sarabia N, Bateson RE, Dahl NP, Crooks AM, Kuruc JD, Margolis DM, Archin NM. Soriano-Sarabia N, et al. J Virol. 2014 Dec;88(24):14070-7. doi: 10.1128/JVI.01900-14. Epub 2014 Sep 24. J Virol. 2014. PMID: 25253353 Free PMC article.

4

Eradicating HIV-1 infection: seeking to clear a persistent pathogen.

Archin NM, Sung JM, Garrido C, Soriano-Sarabia N, Margolis DM. Archin NM, et al. Nat Rev Microbiol. 2014 Nov;12(11):750-64. doi: 10.1038/nrmicro3352. Nat Rev Microbiol. 2014. PMID: 25402363 Free PMC article. Review.

5

Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection.

Soriano-Sarabia N, Archin NM, Bateson R, Dahl NP, Crooks AM, Kuruc JD, Garrido C, Margolis DM. Soriano-Sarabia N, et al. PLoS Pathog. 2015 Oct 16;11(10):e1005201. doi: 10.1371/journal.ppat.1005201. eCollection 2015 Oct. PLoS Pathog. 2015. PMID: 26473478 Free PMC article.

6

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function.

Garrido C, Spivak AM, Soriano-Sarabia N, Checkley MA, Barker E, Karn J, Planelles V, Margolis DM. Garrido C, et al. Front Immunol. 2016 Sep 21;7:356. doi: 10.3389/fimmu.2016.00356. eCollection 2016. Front Immunol. 2016. PMID: 27708642 Free PMC article.

7

Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo.

Garrido C, Abad-Fernandez M, Tuyishime M, Pollara JJ, Ferrari G, Soriano-Sarabia N, Margolis DM. Garrido C, et al. J Virol. 2018 May 29;92(12):e00235-18. doi: 10.1128/JVI.00235-18. Print 2018 Jun 15. J Virol. 2018. PMID: 29593039 Free PMC article.

8

γδ T cells: an immunotherapeutic approach for HIV cure strategies.

Garrido C, Clohosey ML, Whitworth CP, Hudgens M, Margolis DM, Soriano-Sarabia N. Garrido C, et al. JCI Insight. 2018 Jun 21;3(12):e120121. doi: 10.1172/jci.insight.120121. eCollection 2018 Jun 21. JCI Insight. 2018. PMID: 29925697 Free PMC article.

9

Measuring the contribution of γδ T cells to the persistent HIV reservoir.

James KS, Trumble I, Clohosey ML, Moeser M, Roan NR, Adimora AA, Joseph SB, Archin NM, Hudgens M, Soriano-Sarabia N. James KS, et al. AIDS. 2020 Mar 1;34(3):363-371. doi: 10.1097/QAD.0000000000002434. AIDS. 2020. PMID: 31764074 Free PMC article.

10

Correction for Garrido et al., "Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo".

Garrido C, Abad-Fernandez M, Tuyishime M, Pollara JJ, Ferrari G, Soriano-Sarabia N, Margolis DM. Garrido C, et al. J Virol. 2020 May 18;94(11):e00223-20. doi: 10.1128/JVI.00223-20. Print 2020 May 18. J Virol. 2020. PMID: 32423966 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page